CNS vs. MEDP
CNS (Cohen & Steers, Inc.) and MEDP (Medpace Holdings, Inc.) are both stocks. CNS operates in Asset Management (Financial Services), while MEDP operates in Diagnostics & Research (Healthcare). Over the past 5 years, CNS returned 3.28%/yr vs 26.82%/yr for MEDP. Their 0.33 correlation means their historical movements had little consistent relationship.
Performance
CNS vs. MEDP - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CNS achieves a 33.64% return, which is significantly higher than MEDP's 2.75% return.
CNS
- 1D
- 0.86%
- 1M
- 4.71%
- 6M
- 30.56%
- YTD
- 33.64%
- 1Y
- 18.25%
- 3Y*
- 12.67%
- 5Y*
- 3.28%
- 10Y*
- 12.13%
- ALL TIME*
- 13.77%
MEDP
- 1D
- -0.21%
- 1M
- 3.50%
- 6M
- -0.92%
- YTD
- 2.75%
- 1Y
- 36.40%
- 3Y*
- 31.18%
- 5Y*
- 26.82%
- 10Y*
- —
- ALL TIME*
- 35.39%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $21.24M | $22.05M | $21.83M | |
| $292.94M | $222.04M | $171.72M |
CNS vs. MEDP - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CNS Cohen & Steers, Inc. | 33.64% | -29.77% | 25.53% | 21.84% | -28.00% | 29.00% | 23.45% | 93.97% | -19.74% | 48.05% |
MEDP Medpace Holdings, Inc. | 2.75% | 69.05% | 8.38% | 44.31% | -2.40% | 56.35% | 65.60% | 58.81% | 45.97% | 0.53% |
Correlation
The correlation between CNS and MEDP is 0.25, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.25 |
Correlation (3Y) Balances recent behavior with more history. | 0.34 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.39 |
Correlation (All Time) Calculated using the full available price history since Aug 11, 2016 | 0.33 |
The correlation between CNS and MEDP shifts across timeframes, from 0.25 (1 year) to 0.39 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
CNS:
$4.23B
MEDP:
$16.11B
CNS:
$3.26
MEDP:
$16.89
CNS:
25.26
MEDP:
34.17
CNS:
7.10
MEDP:
6.04
CNS:
7.24
MEDP:
38.26
CNS:
$599.09M
MEDP:
$2.78B
CNS:
$458.91M
MEDP:
$800.22M
CNS:
$226.36M
MEDP:
$613.10M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CNS vs. MEDP — Risk / Return Rank
CNS
MEDP
CNS vs. MEDP - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Cohen & Steers, Inc. (CNS) and Medpace Holdings, Inc. (MEDP). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CNS | MEDP | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.20 | ||
| Sortino ratioReturn per unit of downside risk | -0.20 | ||
| Omega ratioGain probability vs. loss probability | 1.12 | 1.21 | -0.09 |
| Calmar ratioReturn relative to maximum drawdown | 0.69 | 0.96 | -0.27 |
| Martin ratioReturn relative to average drawdown | 1.27 | 2.04 | -0.77 |
Loading charts...
Drawdowns
CNS vs. MEDP - Drawdown Comparison
The maximum CNS drawdown since its inception was -85.40%, which is greater than MEDP's maximum drawdown of -42.87%. Use the drawdown chart below to compare losses from any high point for CNS and MEDP.
Loading charts...
Drawdown Indicators
| CNS | MEDP | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -85.40% | -42.87% | -42.53% |
Max Drawdown (1Y)Largest decline over 1 year | -23.32% | -36.61% | +13.29% |
Max Drawdown (3Y)Largest decline over 3 years | -42.59% | -39.38% | -3.21% |
Max Drawdown (5Y)Largest decline over 5 years | -46.25% | -42.87% | -3.38% |
Max Drawdown (10Y)Largest decline over 10 years | -55.06% | — | — |
Current DrawdownCurrent decline from peak | -18.70% | -7.01% | -11.69% |
Average DrawdownAverage peak-to-trough decline | -23.19% | -12.94% | -10.25% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 12.74% | 17.24% | -4.50% |
Volatility
CNS vs. MEDP - Volatility Comparison
The current volatility for Cohen & Steers, Inc. (CNS) is 8.35%, while Medpace Holdings, Inc. (MEDP) has a volatility of 16.14%. This indicates that CNS experiences smaller price fluctuations and is considered to be less risky than MEDP based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CNS | MEDP | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.35% | 16.14% | -7.79% |
Volatility (6M)Calculated over the trailing 6-month period | 18.64% | 41.25% | -22.61% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.28% | 44.64% | -17.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 30.27% | 52.09% | -21.82% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.05% | 49.81% | -16.76% |
Dividends
CNS vs. MEDP - Dividend Comparison
CNS's dividend yield for the trailing twelve months is around 3.14%, while MEDP has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CNS Cohen & Steers, Inc. | 3.14% | 3.95% | 2.56% | 3.01% | 3.41% | 3.30% | 3.45% | 5.48% | 11.13% | 4.48% | 4.58% | 5.43% |
MEDP Medpace Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
CNS vs. MEDP - Financials Comparison
This section allows you to compare key financial metrics between Cohen & Steers, Inc. and Medpace Holdings, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
CNS vs. MEDP - Profitability Comparison
CNS - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Cohen & Steers, Inc. reported a gross profit of 147.42M and revenue of 166.92M. Therefore, the gross margin over that period was 88.3%.
MEDP - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported a gross profit of 201.64M and revenue of 707.33M. Therefore, the gross margin over that period was 28.5%.
CNS - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Cohen & Steers, Inc. reported an operating income of 66.96M and revenue of 166.92M, resulting in an operating margin of 40.1%.
MEDP - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported an operating income of 146.82M and revenue of 707.33M, resulting in an operating margin of 20.8%.
CNS - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Cohen & Steers, Inc. reported a net income of 49.34M and revenue of 166.92M, resulting in a net margin of 29.6%.
MEDP - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Medpace Holdings, Inc. reported a net income of 121.36M and revenue of 707.33M, resulting in a net margin of 17.2%.
Frequently Asked Questions
CNS and MEDP have a correlation of 0.25, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MEDP has higher volatility (16.14%) compared to CNS (8.35%). In terms of maximum drawdown, CNS dropped -85.40% vs MEDP's -42.87%.
MEDP currently has the higher Sharpe Ratio (0.79 vs 0.59), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CNS and MEDP
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer